Corneal collagen cross-linking for treating keratoconus.

@article{Sykakis2015CornealCC,
  title={Corneal collagen cross-linking for treating keratoconus.},
  author={Evripidis Sykakis and Rushmia Karim and Jennifer R. Evans and Catey Bunce and Kwesi Nyan Amissah-Arthur and Showrob Patwary and P J Mcdonnell and Samer Hamada},
  journal={The Cochrane database of systematic reviews},
  year={2015},
  volume={3},
  pages={CD010621}
}
BACKGROUND Keratoconus is a condition of the eye that affects approximately 1 in 2000 people. The disease leads to a gradual increase in corneal curvature and decrease in visual acuity with consequent impact on quality of life. Collagen cross-linking (CXL) with ultraviolet A (UVA) light and riboflavin (vitamin B2) is a relatively new treatment that has been… CONTINUE READING